Corvus Pharmaceuticals
CRVS
#6513
Rank
S$1.05 B
Marketcap
S$12.47
Share price
-3.40%
Change (1 day)
11.45%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2026 (TTM): -S$69.76 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$19.72 Million, an increase over its 2024 earnings that were of -S$80.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$69.76 Million253.79%
2025 -S$19.72 Million-75.47%
2024 -S$80.36 Million130.47%
2023 -S$34.87 Million-34.57%
2022 -S$53.29 Million-4.47%
2021 -S$55.79 Million621.28%
2020 -S$7.74 Million-87.16%
2019 -S$60.21 Million-0.57%
2018 -S$60.56 Million-15.67%
2017 -S$71.81 Million53.03%
2016 -S$46.93 Million16.08%
2015 -S$40.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.21 Billion 188.45%๐Ÿ‡บ๐Ÿ‡ธ USA